SEC Comment Letter 0000000000-23-005994 to BiomX Inc. (PHGE)
BiomX Inc.
Date: June 6, 2023 · CIK: 0001739174 · Accession: 0000000000-23-005994
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-272371
Letter
United States securities and exchange commission logo June 6, 2023 Marina Wolfson Chief Financial Officer BiomX Inc. 22 Einstein St., Floor 4 Ness Ziona, Israel 7414003 Re:BiomX Inc. Registration Statement on Form S-3 Filed June 2, 2023 File No. 333-272371 Dear Marina Wolfson: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Howard E. Berkenblit
Show Raw Text
United States securities and exchange commission logo
June 6, 2023
Marina Wolfson
Chief Financial Officer
BiomX Inc.
22 Einstein St., Floor 4
Ness Ziona, Israel 7414003
Re:BiomX Inc.
Registration Statement on Form S-3
Filed June 2, 2023
File No. 333-272371
Dear Marina Wolfson:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jimmy McNamara at 202-551-7349 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Howard E. Berkenblit